Unit
Department of Radiation Oncology
RO · Dept. IV
Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Schaule J, Lohaus F, Abbasi-Senger N, Henke G, Szuecs M, Geier M, Sundahl N, Buergy D, Dummer R, Eckert F, Adebahr S, Schymalla M, Kroeze S, Blanck O, Stera S, Kahl K, Roeder F, Combs S, Kaul D, Claes A, Guckenberger M. Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score. Radiat Oncol 2020; 15:280.
Dec 14, 2020Correction to: Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Dec 14, 2020Radiat Oncol 2020; 15:280
Schaule Jana, Lohaus Fabian, Abbasi-Senger Nasrin, Henke Guido, Szuecs Marcella, Geier Michael, Sundahl Nora, Buergy Daniel, Dummer Reinhard, Eckert Franziska, Adebahr Sonja, Schymalla Markus M, Kroeze Stephanie G C, Blanck Oliver, Stera Susanne, Kahl Klaus H, Roeder Falk, Combs Stephanie E, Kaul David, Claes An, Guckenberger Matthias
Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine
Glatzer M, Dziadziuszko R, Belderbos J, Ricardi U, Manapov F, Lievens Y, Geets X, Dieckmann K, Guckenberger M, Andratschke N, Süveg K, Le Pechoux C, McDonald F, Faivre-Finn C, De Ruysscher D, Widder J, Van Houtte P, Troost E, Slotman B, Ramella S, Pöttgen C, Peeters S, Nestle U, Putora P. Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine. Radiother Oncol 2020; 154:269-273.
Nov 11, 2020Role of radiotherapy in the management of brain metastases of NSCLC - Decision criteria in clinical routine
Nov 11, 2020Radiother Oncol 2020; 154:269-273
Glatzer Markus, Dziadziuszko Rafal, Belderbos Jose, Ricardi Umberto, Manapov Farkhad, Lievens Yolande, Geets Xavier, Dieckmann Karin, Guckenberger Matthias, Andratschke Nicolaus, Süveg Krisztian, Le Pechoux Cecile, McDonald Fiona, Faivre-Finn Corinne, De Ruysscher Dirk, Widder Joachim, Van Houtte Paul, Troost Esther G C, Slotman Ben J, Ramella Sara, Pöttgen Christoph, Peeters Stephanie T H, Nestle Ursula, Putora Paul Martin
Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy
Iseli T, Berghmans T, Glatzer M, Rittmeyer A, Massard G, Durieux V, Buchsbaum T, Putora P. Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy. ERJ Open Res 2020; 6
Sep 14, 2020Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy
Sep 14, 2020ERJ Open Res 2020; 6
Iseli Thomas, Berghmans Thierry, Glatzer Markus, Rittmeyer Achim, Massard Gilbert, Durieux Valérie, Buchsbaum Thomas, Putora Paul Martin
Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI)
Steffen T, Yutaka Y, Paul S, Beate R, Quadros C, Pompiliu P, Morris D, Moran B, Yan L, Ignace d, Goere D, Glehen O, Glatzer M, Lana B, Häller L, Putora P. Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI). Oncology 2020; 99:41-48.
Sep 11, 2020Decision-Making Analysis for Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer: A Survey by the Executive Committee of the Peritoneal Surface Oncology Group International (PSOGI)
Sep 11, 2020Oncology 2020; 99:41-48
Steffen Thomas, Yutaka Yonemura, Paul Sugarbaker, Beate Rau, Quadros Claudio A, Pompiliu Piso, Morris David L, Moran Brendan J, Yan Li, Ignace de Hingh, Goere Diane, Glehen Olivier, Glatzer Markus, Lana Bijelic, Häller Lukas, Putora Paul Martin
Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International Experts
Steffen T, Yutaka Y, Paul S, Beate R, Claudio Q, Pompiliu P, David M, Brandon M, Yan L, Ignace d, Goere D, Glehen O, Glatzer M, Lana B, Eden J, Martin P. Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International Experts. Clin Colorectal Cancer 2020; 19:277-284.
Jul 15, 2020Patient Selection for Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Cancer: Consensus on Decision Making Among International Experts
Jul 15, 2020Clin Colorectal Cancer 2020; 19:277-284
Steffen Thomas, Yutaka Yonemura, Paul Sugarbaker, Beate Rau, Claudio Quadros, Pompiliu Piso, David Morris, Brandon Moran, Yan Li, Ignace de Hingh, Goere Diane, Glehen Olivier, Glatzer Markus, Lana Bijelic, Eden Janina, Martin Putora Paul
Radiotherapy for lentigo maligna and lentigo maligna melanoma - a systematic review.
Hendrickx A, Cozzio A, Plasswilm L, Panje C. Radiotherapy for lentigo maligna and lentigo maligna melanoma - a systematic review. Radiat Oncol 2020; 15:174.
Jul 14, 2020Radiotherapy for lentigo maligna and lentigo maligna melanoma - a systematic review.
Jul 14, 2020Radiat Oncol 2020; 15:174
Hendrickx Alexandra, Cozzio Antonio, Plasswilm Ludwig, Panje Cédric M
ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer
Le Pechoux C, Van Houtte P, Hurkmans C, Lievens Y, Peeters S, Dziadiuszko R, Pöttgen C, Belderbos J, Geets X, Ricardi U, De Ruysscher D, Slotman B, Putora P, Manapov F, McDonald F, Ramella S, Faivre-Finn C, Nestle U. ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer. Radiother Oncol 2020; 152:89-95.
Jul 13, 2020ESTRO ACROP guidelines for target volume definition in the thoracic radiation treatment of small cell lung cancer
Jul 13, 2020Radiother Oncol 2020; 152:89-95
Le Pechoux Cecile, Van Houtte Paul, Hurkmans Coen, Lievens Yolande, Peeters Stephanie, Dziadiuszko Rafal, Pöttgen Christoph, Belderbos Jose, Geets Xavier, Ricardi Umberto, De Ruysscher Dirk, Slotman Ben, Putora Paul Martin, Manapov Farkhad, McDonald Fiona, Ramella Sara, Faivre-Finn Corinne, Nestle Ursula
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Opitz I, Greillier L, Hoda M, Klepetko W, Lacourt A, McElnay P, Maskell N, Mutti L, Pairon J, Van Schil P, van Meerbeeck J, Waller D, Weder W, Putora P, Galateau-Salle F, Fennell D, Scherpereel A, Berghmans T, Psallidas I, Glatzer M, Rigau D, Astoul P, Bölükbas S, Boyd J, Coolen J, De Bondt C, De Ruysscher D, Durieux V, Faivre-Finn C, Cardillo G. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2020; 58:1-24.
Jul 1, 2020ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Jul 1, 2020Eur J Cardiothorac Surg. 2020; 58:1-24
Opitz Isabelle, Greillier Laurent, Hoda Mir Ali, Klepetko Walter, Lacourt Aude, McElnay Phil, Maskell Nick A, Mutti Luciano, Pairon Jean-Claude, Van Schil Paul, van Meerbeeck Jan P, Waller David, Weder Walter, Putora Paul Martin, Galateau-Salle Francoise, Fennell Dean A, Scherpereel Arnaud, Berghmans Thierry, Psallidas Ioannis, Glatzer Markus, Rigau David, Astoul Philippe, Bölükbas Servet, Boyd Jeanette, Coolen Johan, De Bondt Charlotte, De Ruysscher Dirk, Durieux Valérie, Faivre-Finn Corinne, Cardillo Giuseppe
ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Scherpereel A, Greillier L, Hoda M, Klepetko W, Lacourt A, McElnay P, Maskell N, Mutti L, Pairon J, Van Schil P, van Meerbeeck J, Waller D, Weder W, Cardillo G, Galateau-Salle F, Fennell D, Opitz I, Berghmans T, Psallidas I, Glatzer M, Rigau D, Astoul P, Bölükbas S, Boyd J, Coolen J, De Bondt C, De Ruysscher D, Durieux V, Faivre-Finn C, Putora P. ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma. Eur Respir J. 2020; 55
Jun 11, 2020ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma
Jun 11, 2020Eur Respir J. 2020; 55
Scherpereel Arnaud, Greillier Laurent, Hoda Mir Ali, Klepetko Walter, Lacourt Aude, McElnay Phil, Maskell Nick A, Mutti Luciano, Pairon Jean-Claude, Van Schil Paul, van Meerbeeck Jan P, Waller David, Weder Walter, Cardillo Giuseppe, Galateau-Salle Francoise, Fennell Dean, Opitz Isabelle, Berghmans Thierry, Psallidas Ioannis, Glatzer Markus, Rigau David, Astoul Philippe, Bölükbas Servet, Boyd Jeanette, Coolen Johan, De Bondt Charlotte, De Ruysscher Dirk, Durieux Valérie, Faivre-Finn Corinne, Putora Paul Martin
A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives
Achard V, Matzinger O, Peguret N, Pesce G, Putora P, Reuter C, Richetti A, Vees H, Vrieling C, Zaugg K, Zimmermann F, Zwahlen D, Tsoutsou P, Kaouthar K, Huck C, Herrmann E, Aebersold D, Allal A, Andratschke N, Baumert B, Beer K, Betz M, Breuneval T, Bodis S, De Bari B, Förster R, Franzetti-Pellanda A, Guckenberger M, Zilli T. A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives. Radiother Oncol 2020; 150:1-3.
Jun 6, 2020A national survey on radiation oncology patterns of practice in Switzerland during the COVID-19 pandemic: Present changes and future perspectives
Jun 6, 2020Radiother Oncol 2020; 150:1-3
Achard Vérane, Matzinger Oscar, Peguret Nicolas, Pesce Gianfranco, Putora Paul Martin, Reuter Christiane, Richetti Antonella, Vees Hansjörg, Vrieling Conny, Zaugg Kathrin, Zimmermann Frank, Zwahlen Daniel R, Tsoutsou Pelagia, Kaouthar Khanfir, Huck Constance, Herrmann Evelyn, Aebersold Daniel M, Allal Abdelkarim S, Andratschke Nicolaus, Baumert Brigitta G, Beer Karl T, Betz Michael, Breuneval Thomas, Bodis Stephan, De Bari Berardino, Förster Robert, Franzetti-Pellanda Alessandra, Guckenberger Matthias, Zilli Thomas
Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Schaule J, Lohaus F, Abbasi-Senger N, Henke G, Szuecs M, Geier M, Sundahl N, Buergy D, Dummer R, Eckert F, Adebahr S, Schymalla M, Kroeze S, Blanck O, Stera S, Kahl K, Roeder F, Combs S, Kaul D, Claes A, Guckenberger M. Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score. Radiat Oncol 2020; 15:135.
Jun 1, 2020Predicting survival in melanoma patients treated with concurrent targeted- or immunotherapy and stereotactic radiotherapy : Melanoma brain metastases prognostic score
Jun 1, 2020Radiat Oncol 2020; 15:135
Schaule Jana, Lohaus Fabian, Abbasi-Senger Nasrin, Henke Guido, Szuecs Marcella, Geier Michael, Sundahl Nora, Buergy Daniel, Dummer Reinhard, Eckert Franziska, Adebahr Sonja, Schymalla Markus M, Kroeze Stephanie G C, Blanck Oliver, Stera Susanne, Kahl Klaus H, Roeder Falk, Combs Stephanie E, Kaul David, Claes An, Guckenberger Matthias
Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise
Glatzer M, Belderbos J, Dziadziuszko R, Le Pechoux C, McDonald F, Nestle U, Peeters S, Pöttgen C, Ramella S, Slotman B, Dahele M, Troost E, Van Houtte P, Widder J, De Ruysscher D, Faivre-Finn C, Putora P. Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise. Radiother Oncol 2020; 150:26-29.
May 22, 2020Once daily versus twice-daily radiotherapy in the management of limited disease small cell lung cancer - Decision criteria in routine practise
May 22, 2020Radiother Oncol 2020; 150:26-29
Glatzer Markus, Belderbos Jose, Dziadziuszko Rafal, Le Pechoux Cecile, McDonald Fiona, Nestle Ursula, Peeters Stephanie T H, Pöttgen Christoph, Ramella Sara, Slotman Ben J, Dahele M R, Troost Esther G C, Van Houtte Paul, Widder Joachim, De Ruysscher Dirk, Faivre-Finn Corinne, Putora Paul Martin
Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology
Iseli T, Plasswilm L, Sirén C, Schmidt B, Rothermundt C, Hundsberger T, Glatzer M, Panje C, Fischer G, Putora P. Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology. Oncology 2020; 98:438-444.
May 19, 2020Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology
May 19, 2020Oncology 2020; 98:438-444
Iseli Thomas, Plasswilm Ludwig, Sirén Charlotta, Schmidt Barbara, Rothermundt Christian, Hundsberger Thomas, Glatzer Markus, Panje Cédric, Fischer Galina, Putora Paul Martin
Oncology Informatics: Status Quo and Outlook
Putora P, Baudis M, Beadle B, El Naqa I, Giordano F, Nicolay N. Oncology Informatics: Status Quo and Outlook. Oncology 2020; 98:329-331.
May 14, 2020Oncology Informatics: Status Quo and Outlook
May 14, 2020Oncology 2020; 98:329-331
Putora Paul Martin, Baudis Michael, Beadle Beth M, El Naqa Issam, Giordano Frank A, Nicolay Nils H
PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial
De Bruycker A, Guckenberger M, Heikkilä R, Putora P, Zapatero A, Conde-Moreno A, Couñago F, Vanhoutte F, Goetghebeur E, Reynders D, Zilli T, Ameye F, Siva S, Shelan M, Spiessens A, Dirix P, Koutsouvelis N, Semac I, Liefhooghe N, Gomez-Iturriaga A, Everaerts W, Otte F, Papachristofilou A, Scorsetti M, Ost P. PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial. BMC cancer 2020; 20:406.
May 12, 2020PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial
May 12, 2020BMC cancer 2020; 20:406
De Bruycker A, Guckenberger M, Heikkilä R, Putora Paul Martin, Zapatero A, Conde-Moreno A, Couñago F, Vanhoutte F, Goetghebeur E, Reynders D, Zilli T, Ameye F, Siva S, Shelan M, Spiessens A, Dirix P, Koutsouvelis N, Semac I, Liefhooghe N, Gomez-Iturriaga A, Everaerts W, Otte F, Papachristofilou A, Scorsetti M, Ost P
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
Troost E, Nestle U, Putora P, Bussink J. Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother Oncol 2020; 147:227-228.
Apr 24, 2020Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement
Apr 24, 2020Radiother Oncol 2020; 147:227-228
Troost Esther G C, Nestle Ursula, Putora Paul Martin, Bussink Johan
Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts
Putora P, Pöttgen C, Reck M, Blackhall F, Cappuzzo F, Besse B, Novello S, Garrido P, Felip E, O'Brien M, Paz Ares L, de Marinis F, Westeel V, Widder J, Peeters S, Troost E, Fischer G, Früh M, Califano R, Faivre-Finn C, Van Houtte P, McDonald F, Nestle U, Dziadziuszko R, Le Péchoux C, Ramella S, Belderbos J, Slotman B, De Ruysscher D. Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts. Radiother Oncol 2020; 149:84-88.
Apr 20, 2020Treatment of brain metastases in small cell lung cancer: Decision-making amongst a multidisciplinary panel of European experts
Apr 20, 2020Radiother Oncol 2020; 149:84-88
Putora Paul Martin, Pöttgen C, Reck M, Blackhall F, Cappuzzo F, Besse B, Novello S, Garrido P, Felip E, O'Brien M, Paz Ares L, de Marinis F, Westeel V, Widder J, Peeters S, Troost E G C, Fischer G F, Früh Martin, Califano R, Faivre-Finn C, Van Houtte P, McDonald F, Nestle U, Dziadziuszko R, Le Péchoux C, Ramella S, Belderbos J, Slotman B J, De Ruysscher D
Choice of first line systemic treatment in pancreatic cancer among national experts
Glatzer M, Pless M, Pederiva S, Pestalozzi B, Berger M, Inauen R, Winterhalder R, Montemurro M, Horber D, Putora P. Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology 2020; 20 (2020):686-690.
Mar 31, 2020Choice of first line systemic treatment in pancreatic cancer among national experts
Mar 31, 2020Pancreatology 2020; 20 (2020):686-690
Glatzer Markus, Pless Miklos, Pederiva S., Pestalozzi Bernhard, Berger M.D., Inauen Roman, Winterhalder Ralf, Montemurro Michael, Horber Daniel, Putora Paul Martin
Choice of first line systemic treatment in pancreatic cancer among national experts
Glatzer M, Pless M, Pederiva S, Pestalozzi B, Berger M, Inauen R, Winterhalder R, Montemurro M, Horber D, Putora P. Choice of first line systemic treatment in pancreatic cancer among national experts. Pancreatology 2020; 20:686-690.
Mar 31, 2020Choice of first line systemic treatment in pancreatic cancer among national experts
Mar 31, 2020Pancreatology 2020; 20:686-690
Glatzer Markus, Pless M, Pederiva S, Pestalozzi B, Berger M D, Inauen R, Winterhalder R, Montemurro M, Horber D, Putora Paul Martin
Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts
Früh M, De Ruysscher D, Westeel V, de Marinis F, Paz Ares L, O'Brien M, Felip E, Garrido P, Novello S, Besse B, Cappuzzo F, Califano R, Blackhall F, Reck M, Panje C, Putora P. Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts. Lung Cancer 2020; 146:6-11.
Mar 30, 2020Choice of second-line systemic therapy in stage IV small cell lung cancer (SCLC) - A decision-making analysis amongst European lung cancer experts
Mar 30, 2020Lung Cancer 2020; 146:6-11
Früh Martin, De Ruysscher D, Westeel V, de Marinis F, Paz Ares L, O'Brien M, Felip E, Garrido P, Novello S, Besse B, Cappuzzo F, Califano R, Blackhall F, Reck M, Panje C M, Putora Paul Martin